Inflammatory Biomarkers Improve Clinical Prediction of Mortality in Chronic Obstructive Pulmonary Disease
Bartolomé R. Celli(Brigham and Women's Hospital), Àlvar Agustí(Centro de Investigación Biomédica en Red de Enfermedades Respiratorias), Nicholas Locantore(Research Triangle Park Foundation), Edwin K. Silverman(Brigham and Women's Hospital), Ruth Tal‐Singer, Bruce E. Miller, Lisa Edwards(Research Triangle Park Foundation), Annelyse Duvoix(University of Cambridge), William MacNee(The Queen's Medical Research Institute), Per Bakke(University of Bergen), Emiel F.�M. Wouters(Maastricht University), Harvey O. Coxson(University of British Columbia), Courtney Crim(GlaxoSmithKline (United States)), Stephen I. Rennard(University of Nebraska at Omaha), Jørgen Vestbo(Manchester Academic Health Science Centre), Peter M.A. Calverley(University of Liverpool), David A. Lomas(Institute of Structural and Molecular Biology), Julie Yates(GlaxoSmithKline (United States))
Cited by 430
Related Papers
Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper
|European Respiratory Journal|2004|4.4k
An Official American Thoracic Society/European Respiratory Society Statement: Key Concepts and Advances in Pulmonary Rehabilitation
|American Journal of Respiratory and Critical Care Medicine|2013|3.8k
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary
|American Journal of Respiratory and Critical Care Medicine|2017|3.2k
Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
|New England Journal of Medicine|2010|3k
American Thoracic Society/European Respiratory Society Statement on Pulmonary Rehabilitation
|American Journal of Respiratory and Critical Care Medicine|2006|2k